AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining the Future of Human Health

DUBAI, United Arab Emirates, Jan. 31, 2026 (GLOBE NEWSWIRE) — Building on the unprecedented success of its 2025 Masterclass, AEON Clinic, the Middle East’s pioneer in regenerative wellness, proudly announces the Next Generation Medicine Congress 2026. This transformative four-day event will take place from 13th to 16th April 2026 at the iconic Atlantis The Palm, Dubai.

The 2026 Congress marks a significant evolution for AEON, transitioning from an intensive medical masterclass into a full-scale international platform. The event is set to convene a prestigious assembly of global scientists, researchers, and tech innovators dedicated to advancing the science of human longevity and defining the future of healthcare.

“The 2025 Masterclass proved there is an immense global appetite for evidence-based longevity medicine,” said Dr. Jaffer Khan, Founder and Medical Director of AEON Clinic. “For 2026, we are expanding our horizons. This Congress is not just an event; it is a global stage where the most brilliant minds will bridge the gap between laboratory breakthroughs and clinical reality, right here in the heart of Dubai.”

A Vision for the Future of Health

The Next-Generation Medicine Congress 2026 will feature the pillars of modern medical evolution:

  • Biological Age Reversal: Exploring the latest protocols in cellular rejuvenation and life-extension.
  • Regenerative Therapeutics: Deep dives into stem cell therapy, CRISPR gene editing, and CAR-T innovations.
  • Precision & AI-Driven Medicine: Utilizing multi-omics and AI to deliver personalized patient care.
  • Hands-on Clinical Workshops: Practical training for practitioners in advanced aesthetic and regenerative procedures.

As an affiliate of the American Board of Regenerative Medicine and partner of the Geneva College of Longevity Science, AEON Clinic continues to lead the region in medical education. The 2026 Congress will offer CME-accredited sessions, ensuring healthcare professionals remain at the forefront of this evolving field.

Event Details

About AEON Clinic

AEON Clinic is a premier regenerative wellness centre located at Atlantis The Royal, Dubai. Specialized in longevity and precision medicine, the clinic combines cutting-edge science including genomics, stem cell therapy, and mitochondrial medicine with luxury hospitality experience.

Email: info@theaeonclinic.com

Phone: +971 4 518 5777

Website: www.theaeonclinic.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/11e9ae96-2211-4d15-ab7a-cd9f4626e945

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

44 minutes ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

1 day ago